These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 12716263)

  • 21. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging.
    Catani M; Cherubini A; Howard R; Tarducci R; Pelliccioli GP; Piccirilli M; Gobbi G; Senin U; Mecocci P
    Neuroreport; 2001 Aug; 12(11):2315-7. PubMed ID: 11496102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia.
    Targosz-Gajniak MG; Siuda JS; Wicher MM; Banasik TJ; Bujak MA; Augusciak-Duma AM; Opala G
    J Neurol Sci; 2013 Dec; 335(1-2):58-63. PubMed ID: 24035276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: a nonrandomised controlled trial with magnetic resonance spectroscopy.
    Modrego PJ; Pina MA; Fayed N; Díaz M
    CNS Drugs; 2006; 20(10):867-77. PubMed ID: 16999455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of 1H spectroscopy to a brief cognitive-functional test battery for the diagnosis of mild Alzheimer's disease.
    Silveira de Souza A; de Oliveira-Souza R; Moll J; Tovar-Moll F; Andreiuolo PA; Bottino CM
    Dement Geriatr Cogn Disord; 2011; 32(5):351-61. PubMed ID: 22311276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proton magnetic resonance spectroscopy of late-life major depressive disorder.
    Chen CS; Chiang IC; Li CW; Lin WC; Lu CY; Hsieh TJ; Liu GC; Lin HF; Kuo YT
    Psychiatry Res; 2009 Jun; 172(3):210-4. PubMed ID: 19303260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
    Shonk TK; Moats RA; Gifford P; Michaelis T; Mandigo JC; Izumi J; Ross BD
    Radiology; 1995 Apr; 195(1):65-72. PubMed ID: 7892497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment.
    O'Brien JT; Desmond P; Ames D; Schweitzer I; Chiu E; Tress B
    Psychol Med; 1997 Nov; 27(6):1267-75. PubMed ID: 9403898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
    Voevodskaya O; Sundgren PC; Strandberg O; Zetterberg H; Minthon L; Blennow K; Wahlund LO; Westman E; Hansson O;
    Neurology; 2016 May; 86(19):1754-61. PubMed ID: 27164711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
    Jones RS; Waldman AD
    Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance spectroscopy in common dementias.
    Kantarci K
    Neuroimaging Clin N Am; 2013 Aug; 23(3):393-406. PubMed ID: 23928196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
    Shinno H; Inagaki T; Miyaoka T; Okazaki S; Kawamukai T; Utani E; Inami Y; Horiguchi J
    J Neurol Sci; 2007 Sep; 260(1-2):132-8. PubMed ID: 17540407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
    Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
    Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
    Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
    Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
    Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.
    Hsu YY; Du AT; Schuff N; Weiner MW
    J Geriatr Psychiatry Neurol; 2001; 14(3):145-66. PubMed ID: 11563438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.